Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brain stimulation ...
While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback